RxDoctor Payments Data

Herbert Lazarus

Adolescent Medicine · New York, NYNPI 1730288416

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.3% of the total across 134 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by GSK at 29.8% of the total. Reporting peaked in 2019 at $747 and has fallen 75.8% since, to $181 in 2025. Among adolescent medicine clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,858in general payments, 2019–2025

Across 134 payments — averaging $21.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$853
  • AbbVie$527
  • Sanofi Pasteur Inc.$224
  • Kaleo, Inc.$195
  • Pfizer$148
  • Genentech USA, Inc.$111
  • plus $800 from 20 others

What the payments were for

  • Food & beverage$2,83999%
  • Other$201%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,858 in reported general payments places this provider in the 90th percentile of 257 adolescent medicine providers in New York.

See all adolescent medicine providers in New York

Other adolescent medicine in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →